Polyphenols Nano-Formulations for Topical Delivery and Skin Tissue Engineering

Polyphenols in Human Health and Disease

Volumn 1, Issue , 2013, Pages 839-848

  Menaa, Farid ^a   Menaa, Abder ^b   Menaa, Bouzid ^a  

^a Fluorotronics Inc   (United States)

^b Dept of Clinical Nutrition   (France)

Author keywords

Anti aging skin; Clinical dermatology; Cosmeceutics; Esthetics; Polyphenol nano formulations; Polyphenols bioavailability; Regenerative skin; Skin diseases; Skin engineering; Skin repair; Topically applied polyphenols

Indexed keywords

EID: 84902560317     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398456-2.00065-7     Document Type: Chapter

References (131)

1. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79(5):727-747.
2. D'Archivio M., Filesi C., Di Benedetto R., Gargiulo R., Giovannini C., Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 2007, 43(4):348-361.
3. Menaa F., Menaa A., Tréton J. Polyphenols against skin aging. Human Health and Disease, vol. 1 2013, Academic Press, San Diego, CA, [in press]. R.R. Watson, V.R. Preedy, S. Zibadi (Eds.).
4. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(1 Suppl.):230S-242S.
5. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81(1 Suppl.):243S-255S.
6. Scholz S., Williamson G. Interactions affecting the bioavailability of dietary polyphenols in vivo. Int J Vitam Nutr Res 2007, 77(3):224-235.
7. Nichols J.A., Katiyar S.K. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res 2010, 302(2):71-83.
8. Del Rio D., Costa L.G., Lean M.E.J., Crozier A. Polyphenols and health: what compounds are involved?. Nutr Metab Cardiovasc Dis 2010, 20(1):1-6.
9. Morganti P., Bruno C., Guarneri F., Cardillo A., Del Ciotto P., Valenzano F. Role of topical and nutritional supplement to modify the oxidative stress. Int J Cosmet Sci 2002, 24(6):331-339.
10. Pinnell S.R. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 2003, 48(1):1-19. quiz 20-22.
11. Chow H.H., Cai Y., Hakim I.A., Crowell J.A., Shahi F., Brooks C.A., et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechingallate and polyphenon E in healthy individuals. Clin Cancer Res 2003, 9(9):3312-3319.
12. Koning G.A., Krijger G.C. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. Anticancer Agents Med Chem 2007, 7(4):425-440.
13. Nair H.B., Sung B., Yadav V.R., Kannappan R., Chaturvedi M.M., Aggarwal B.B. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 2010, 80(12):1833-1843.
14. Mousa S.A., Bharali D.J., Armstrong D. From nutraceuticals to pharmaceuticals to nanopharmaceuticals: a case study in angiogenesis modulation during oxidative stress. Mol Biotechnol 2007, 37(1):72-80.
15. Davis M.E., Chen Z.G., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7(9):771-782.
16. Huang Q., Yu H., Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci 2010, 75(1):R50-57.
17. Merisko-Liversidge E.M., Liversidge G.G. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 2008, 36(1):43-48.
18. Wagner V., Dullaart A., Bock A.K., Zweck A. The emerging nanomedicine landscape. Nat Biotechnol 2006, 24(10):1211-1217.
19. Riehemann K., Schneider S.W., Luger T.A., Godin B., Ferrari M., Fuchs H. Nanomedicine - challenge and perspectives. Angew Chem Int Ed Engl 2009, 48(5):872-897.
20. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5(3). 161-71.
21. Epstein H. Cosmeceuticals and polyphenols. Clin Dermatol 2009, 27(5):475-478.
22. Richelle M., Sabatier M., Steiling H., Williamson G. Skin bioavailability of dietary vitamin E, carotenoids, polyphenols, vitamin C, zinc and selenium. Br J Nutr 2006, 96(2):227-238.
23. Korkina L.G., Pastore S., De Luca C., Kostyuk V.A. Metabolism of plant polyphenols in the skin: beneficial versus deleterious effects. Curr Drug Metab 2008, 9(8):710-729.
24. Menaa F., Badole S.L., Menaa B., Menaa A., Bodhankar S.L. Polyphenols: promising therapeutics for inflammatory disease?. Bioactive Foods as Dietary Interventions for Arthritis and Related Inflammatory Diseases 2013, 421-430. CA: Academic Press, San Diego. R.R. Watson, V.R. Preedy (Eds.).
25. Zanwar AA, Badole LS, Menaa F. Curcuma longa: use for skin disease care. In: Watson RR, Zibadi S, editors. Bioactive Dietary Factors and Plant Extracts in Dermatology. New York: Springer; 2013. pp. 391-396.
26. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008, 267(1):133-164.
27. Yang J., Li L., Tan S., Jin H., Qiu J., Mao Q., et al. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection. Fitoterapia 2012, 83(2):348-355.
28. Pacheco-Palencia L.A., Noratto G., Hingorani L., Talcott S.T., Mertens-Talcott S.U. Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. J Agric Food Chem 2008, 56(18):8434-8441.
29. Duarte S., Gregoire S., Singh A.P., Vorsa N., Schaich K., Bowen W.H., et al. Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett 2006, 257(1):50-56.
30. Hsu S. Green tea and the skin. J Am Acad Dermatol 2005, 52(6):1049-1059.
31. Hashim M.S., Devi K.S. Insecticidal action of the polyphenolic rich fractions from the stem bark of Streblus asper on Dysdercus cingulatus. Fitoterapia 2003, 74(7-8):670-676.
32. Menaa F. Latest treatments for metastatic melanoma: what comes next?. J Skin Cancer 2013, 2013:735282.
33. Freedman B.M. Topical polyphenolic antioxidants reduce the adverse effects of intense pulsed light therapy. J Cosmet Laser Ther 2009, 11(3):142-145.
34. Freedman B.M. Topical antioxidant application augments the effects of intense pulsed light therapy. J Cosmet Dermatol 2009, 8(4):254-259.
35. Liang Y.C., Tsai D.C., Lin-Shiau S.Y., Chen C.F., Ho C.T., Lin J.K. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced inflammatory skin edema and ornithine decarboxylase activity by theaflavin-3,3'-digallate in mouse. Nutr Cancer 2002, 42(2):217-223.
36. Afaq F., Ahmad N., Mukhtar H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 2003, 22(58):9254-9264.
37. Yamamoto T., Hsu S., Lewis J., Wataha J., Dickinson D., Singh B., et al. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J Pharmacol Exp Ther 2003, 307(1):230-236.
38. Fujiki H., Suganuma M., Okabe S., Sueoka E., Suga K., Imai K., et al. Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 1999, 220(4):225-228.
39. Katiyar S.K., Agarwal R., Ekker S., Wood G.S., Mukhtar H. Protection against 12-O-tetradecanoylphorbol-13-acetate-caused inflammation in SENCAR mouse ear skin by polyphenolic fraction isolated from green tea. Carcinogenesis 1993, 14(3):361-365.
40. Gali H.U., Perchellet E.M., Perchellet J.P. Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo. Cancer Res 1991, 51(11):2820-2825.
41. Wang Z.Y., Khan W.A., Bickers D.R., Mukhtar H. Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis 1989, 10(2):411-415.
42. Khan W.A., Wang Z.Y., Athar M., Bickers D.R., Mukhtar H. Inhibition of the skin tumorigenicity of (±)-7β,8α-dihydroxy-9α, 10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Lett 1988, 42(1-2):7-12.
43. Menaa F, Menaa A. Skin photoprotection by polyphenols in animal models and humans. In: Watson RR, Preedy VR, Zibadi S, editors. Polyphenols in prevention and treatment of vascular, cardiac disease and cancer. Volume 2. Academic Press, Elsevier Publisher, USA (Accepted).
44. Javed S., Mehrotra N.K., Shukla Y. Chemopreventive effects of black tea polyphenols in mouse skin model of carcinogenesis. Biomed Environ Sci 1998, 11(4):307-313.
45. Katiyar S.K., Mukhtar H. Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols. Carcinogenesis 1997, 18(10):1911-1916.
46. Katiyar S.K., Mohan R.R., Agarwal R., Mukhtar H. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols. Carcinogenesis 1997, 18(3):497-502.
47. Mukhtar H., Katiyar S.K., Agarwal R. Green tea and skin-anticarcinogenic effects. J Invest Dermatol 1994, 102(1):3-7.
48. Afaq F., Katiyar S.K. Polyphenols: skin photoprotection and inhibition of photoCarcinogenesis. Mini Rev Med Chem 2011, 11(14):1200-1215.
49. Katiyar S.K. Green tea prevents non-melanoma skin cancer by enhancing DNA repair. Arch Biochem Biophys 2011, 508(2):152-158.
50. Camouse M.M., Domingo D.S., Swain F.R., Conrad E.P., Matsui M.S., Maes D., et al. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Exp Dermatol 2009, 18(6):522-526.
51. Linden K.G., Carpenter P.M., McLaren C.E., Barr R.J., Hite P., Sun J.D., et al. Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea. Recent Results Cancer Res 2003, 163:165-171. discussion 264-266.
52. Vayalil P.K., Elmets C.A., Katiyar S.K. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 2003, 24(5):927-936.
53. Katiyar S.K., Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol 2001, 69(5):719-726.
54. Elmets C.A., Singh D., Tubesing K., Matsui M., Katiyar S., Mukhtar H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 2001, 44(3):425-432.
55. Katiyar S.K., Elmets C.A., Agarwal R., Mukhtar H. Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol 1995, 62(5):855-861.
56. Katiyar S.K., Agarwal R., Mukhtar H. Inhibition of both stage I and stage II skin tumor promotion in SENCAR mice by a polyphenolic fraction isolated from green tea: inhibition depends on the duration of polyphenol treatment. Carcinogenesis 1993, 14(12):2641-2643.
57. Türkoǧlu M., Uǧurlu T., Gedik G., Yilmaz A.M., Süha Yalçin A. In vivo evaluation of black and green tea dermal products against UV radiation. Drug Discov Ther 2010, 4(5):362-367.
58. Bouzari N., Romagosa Y., Kirsner R.S. Green tea prevents skin cancer by two mechanisms. J Invest Dermatol 2009, 129(5):1054.
59. Korkina L.G., Pastore S., Dellambra E., De Luca C. New molecular and cellular targets for chemoprevention and treatment of skin tumours by plant polyphenols: a critical review. Curr Med Chem 2013, 20(7):852-868.
60. Chiu A.E., Chan J.L., Kern D.G., Kohler S., Rehmus W.E., Kimball A.B. Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. Dermatol Surg 2005, 31(7 Pt 2):855-860. discussion 860.
61. Katiyar S.K., Elmets C.A. Green tea polyphenolic antioxidants and skin photoprotection (Review). Int J Oncol 2001, 18(6):1307-1313.
62. Korkina L.G., De Luca C., Kostyuk V.A., Pastore S. Plant polyphenols and tumors: from mechanisms to therapies, prevention, and protection against toxicity of anti-cancer treatments. Curr Med Chem 2009, 16(30):3943-3965.
63. Menaa B. The importance of nanotechnology in biomedical sciences (Editorial). J Biotechnol Biomaterial 2011, 1:1.
64. Menaa F., Menaa B. Development of mitotane lipid nanocarriers and enantiomers: two-in-one solution to efficiently treat adreno-cortical carcinoma. Curr Med Chem 2012, 19(34):5854-5862.
65. Gibis M., Vogt E., Weiss J. Encapsulation of polyphenolic grape seed extract in polymer-coated liposomes. Food Funct 2012, 3(3):246-254.
66. Fang J.Y., Hung C.F., Hwang T.L., Huang Y.L. Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J Drug Target 2005, 13(1):19-27.
67. Tsai Y.M., Chang-Liao W.L., Chien C.F., Lin L.C., Tsai T.H. Effects of polymer molecular weight on relative oral bioavailability of curcumin. Int J Nanomedicine 2012, 7:2957-2966.
68. Shao S., Li L., Yang G., Li J., Luo C., Gong T., et al. Controlled green tea polyphenols release from electrospun PCL/MWCNTs composite nanofibers. Int J Pharm 2011, 421(2):310-320.
69. Siddiqui I.A., Mukhtar H. Nanochemoprevention by bioactive food components: a perspective. Pharm Res 2010, 27(6):1054-1060.
70. Siddiqui I.A., Adhami V.M., Bharali D.J., Hafeez B.B., Asim M., Khwaja S.I., et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 2009, 69(5):1712-1716.
71. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., Farokhzad O.C. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008, 83(5):761-769.
72. Byrne J.D., Betancourt T., Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008, 60(15):1615-1626.
73. Ranganathan R., Madanmohan S., Kesavan A., Baskar G., Krishnamoorthy Y.R., Santosham R., et al. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications. Int J Nanomedicine 2012, 7:1043-1060.
74. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998, 95(8):4607-4612.
75. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002, 16(10):1217-1226.
76. Dusseault J., Tam S.K., Ménard M., Polizu S., Jourdan G., Yahia L., et al. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res A 2006, 76(2):243-251.
77. Shive M.S., Anderson J.M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997, 28(1):5-24.
78. Makadia H.K., Siegel S.J. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 2011, 3(3):1377-1397.
79. Davaran S., Rashidi M.R., Pourabbas B., Dadashzadeh M., Haghshenas N.M. Adriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization. Int J Nanomedicine 2006, 1(4):535-539.
80. Verderio P., Bonetti P., Colombo M., Pandolfi L., Prosperi D. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. Biomacromolecules 2013, 14(3):672-682.
81. Li S.H., Cai S.X., Liu B., Ma K.W., Wang Z.P., Li X.K. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor. Acta Pharmacol Sin 2006, 27(6):754-759.
82. George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J Control Release 2006, 114(1):1-14.
83. Zhou J., Romero G., Rojas E., Ma L., Moya S., Gao C. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and folic acid binding to achieve selective cell targeting. J Colloid Interface Sci 2010, 345(2):241-247.
84. Wang Q., Jamal S., Detamore M.S., Berkland C. PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. J Biomed Mater Res A 2011, 96(3):520-527.
85. Silva L.F., da Boit K.M. Nanominerals and nanoparticles in feed coal and bottom ash: implications for human health effects. Environ Monit Assess 2011, 174(1-4):187-197.
86. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008, 5(4):505-515.
87. Jain R.K. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987, 47(12):3039-3051.
88. Pasche S., Voros J., Griesser H.J., Spencer N.D., Textor M. Effects of ionic strength and surface charge on protein adsorption at PEGylated surfaces. J Phys Chem B 2005, 109(37):17545-17552.
89. Duncan R., Vicent M.J., Greco F., Nicholson R.I. Polymer-drug conjugates: towards a novel approach for the treatment of endocrine-related cancer. Endocr Relat Cancer 2005, 12(Suppl. 1):S189-199.
90. Simberg D., Duza T., Park J.H., Essler M., Pilch J., Zhang L., et al. Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci USA 2007, 104(3):932-936.
91. Caravan P. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc Chem Res 2009, 42(7):851-862.
92. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5(3):161-171.
93. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2(12):751-760.
94. Rawat M.K., Jain A., Mishra A., Muthu M.S., Singh S. Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Curr Drug Deliv 2010, 7(1):44-50.
95. Ganta S., Amiji M. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 2009, 6(3):928-939.
96. Ganta S., Sharma P., Paxton J.W., Baguley B.C., Garg S. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion. J Drug Target 2010, 18(2):125-133.
97. Anton N., Benoit J.P., Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates - a review. J Control Release 2008, 128(3):185-199.
98. Shakeel F., Ramadan W. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surf B Biointerfaces 2010, 75(1):356-362.
99. Shaikh J., Ankola D.D., Beniwal V., Singh D., Kumar M.N. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009, 37(3-4):223-230.
100. Szoka F., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978, 75(9):4194-4198.
101. Kim S., Martin G.M. Preparation of cell-size unilamellar liposomes with high captured volume and defined size distribution. Biochim Biophys Acta 1981, 646(1):1-9.
102. Meure L.A., Foster N.R., Dehghani F. Conventional and dense gas techniques for the production of liposomes: a review. AAPS PharmSciTech 2008, 9(3):798-809.
103. Barik A., Priyadarsini K.I., Mohan H. Photophysical studies on binding of curcumin to bovine serum albumins. Photochem Photobiol 2003, 77(6):597-603.
104. Schafer-Korting M., Mehnert W., Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007, 59(6):427-443.
105. Shutava T.G., Balkundi S.S., Vangala P., Steffan J.J., Bigelow R.L., Cardelli J.A., et al. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano 2009, 3(7):1877-1885.
106. Barras A., Mezzetti A., Richard A., Lazzaroni S., Roux S., Melnyk P., et al. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm 2009, 379(2):270-277.
107. Siddiqui I.A., Adhami V.M., Chamcheu J.C., Mukhtar H. Impact of nanotecnology in cancer: emphasis on nanochemoprevention. Int J Nanomedicine 2012, 7:591-605.
108. Siddiqui A.I., Shukla Y., Mukhtar H. Nanoencapsulation of natural products for chemoprevention. J Nanomed Nanotechnol 2011, 2:104e.
109. Singh M., Bhatnagar P., Srivastava A.K., Kumar P., Shukla Y., Gupta K.C. Enhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticles. J Biomed Nanotechnol 2011, 7(1):202.
110. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444(7117):337-342.
111. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004, 24(5A):2783-2840.
112. Goswami S.K., Das D.K. Resveratrol and chemoprevention. Cancer Lett 2009, 284(1):1-6.
113. Ahmad N., Adhami V.M., Afaq F., Feyes D.K., Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001, 7(5):1466-1473.
114. Shao J., Li X., Lu X., Jiang C., Hu Y., Li Q., et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces 2009, 72(1):40-47.
115. Jiang H., Zhang L., Kuo J., Kuo K., Gautam S.C., Groc L., et al. Resveratrol-induced apoptotic death in human U251 glioma cells. Mol Cancer Ther 2005, 4(4):554-561.
116. Signorelli P., Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005, 16(8):449-466.
117. Lu Z., Cheng B., Hu Y.L., Zhang Y.H., Zou G.L. Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity. Food Chem 2009, 113(1):17-20.
118. Juan M.E., Buenafuente J., Casals I., Planas J.M. Plasmatic levels of trans-resveratrol in rats. Food Res Int 2002, 35(2-3):195-199.
119. Munin A., Edwards-Lévy F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics 2011, 3(4):793-829.
120. Amri A., Chaumeil J.C., Sfar S., Charrueau C. Administration of resveratrol: what formulation solutions to bioavailability limitations?. J Control Release 2012, 158(2):182-193.
121. Teskac K., Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 2010, 390(1):61-69.
122. Caddeo C., Teskac K., Sinico C., Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 2008, 363(1-2):183-191.
123. Sanna V., Roggio A.M., Siliani S., Piccinini M., Marceddu S., Mariani A., et al. Development of novel cationic chitosan-and anionic alginate-coated poly (d,l-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol. Int J Nanomedicine 2012, 7:5501-5516.
124. Amarnath K., Kumar J., Reddy T., Mahesh V., Ayyappan S.R., Nellore J. Synthesis and characterization of chitosan and grape polyphenols stabilized palladium nanoparticles and their antibacterial activity. Colloids Surf B Biointerfaces 2012, 92:254-261.
125. Katiyar S.K., Vaid M., van Steeg H., Meeran S.M. Green tea polyphenols prevent UV-induced immunosuppression by rapid repair of DNA damage and enhancement of nucleotide excision repair genes. Cancer Prev Res (Phila) 2010, 3(2):179-189.
126. Negrão R., Costa R., Duarte D., Gomes T.T., Azevedo I., Soares R. Different effects of catechin on angiogenesis and inflammation depending on VEGF levels. J Nutr Biochem 2013, 24(2):435-444.
127. Qin Y., Wang H.W., Karuppanapandian T., Kim W. Chitosan green tea polyphenol complex as a released control compound for wound healing. Chin J Traumatol 2010, 13(2):91-95.
128. Klass B.R., Branford O.A., Grobbelaar A.O., Rolfe K.J. The effect of epigallocatechin-3-gallate, a constituent of green tea, on transforming growth factor-β1-stimulated wound contraction. Wound Repair Regen 2010, 18(1):80-88.
129. Park G., Yoon B.S., Moon J.H., Kim B., Jun E.K., Oh S., et al. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. J Invest Dermatol 2008, 128(10):2429-2441.
130. Kostyuk V.A., Potapovich A.I., Suhan T.O., de Luca C., Korkina L.G. Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation. Eur J Pharmacol 2011, 658(2-3):248-256.
131. Pastore S., Lulli D., Fidanza P., Potapovich A.I., Kostyuk V.A., De Luca C., et al. Plant polyphenols regulate chemokine expression and tissue repair in human keratinocytes through interaction with cytoplasmic and nuclear components of epidermal growth factor receptor system. Antioxid Redox Signal 2012, 16(4):314-328.